Nectin-4 PET For Optimizing Enfortumab Vedotin Dose-Response In Urothelial Carcinoma
Akhilesh Mishra, Ajay Sharma, Kuldeep Gupta, Dhanush S. Banka, Burles Avner Johnson, Hoffman-Censits Jean, Peng Huang, David James McConkey, Sridhar Nimmagadda
This paper uses Nectin-4 PET imaging to assess target engagement and optimize dosing of enfortumab vedotin in urothelial carcinoma, finding that PET metrics better predict therapeutic response than dose or baseline expression.
Science Advances · Jan 7, 2026Peer-reviewedCancer Biology